Venture Capital

While he's been an advocate of using the private placement memorandum, there is more to securities law compliance than preparing and using a good PPM, according to Private Placements columnist Matt Storms. Implementing a system to monitor the offering process can help you keep track...

In a dramatic one-year rise, Wisconsin surpassed the $100 million level in annual angel capital investments in 2006, according to a new report by NorthStar Economics. Investment experts believe that bodes well for the state's future ability to attract later-stage venture capital and provide technology...

Researchers studying the pattern of financing for women-owned businesses in the venture capital industry, where women receive only a small fraction of overall investment dollars, have found a similar pattern in the angel capital market. Their findings are consistent with other studies and the anecdotal...

Beyond equity financing, early-stage technology and biotechnology businesses may still have a need for other forms of financing. In this 11th edition of Early Stage, Madison attorney Joe Boucher begins to run through the various business borrowing options....

It's generally a good idea to use a Private Placement Memorandum, or PPM, when offering securities to investors. In this edition of Private Placements, Michael Best & Friedrich attorneys Matt Storms and Dan Ghoca explain the content and the benefits of PPMs, including protection against...

ProCertus BioPharm, an oncology-based pharmaceutical company, has closed on a $2.3 million stock financing led by Venture Investors. ProCertus develops therapeutics to protect cancer patients against the side effects of chemotherapy and radiotherapy, and will use the financing to begin clinical trials on cancer patients. ...

TomoTherapy, a medical systems manufacturer spun out of research at the University of Wisconsin-Madison, has raised $223 million in an initial public offering that concluded on May 9. The Madison-based company will use the proceeds to ramp up its global sales and marketing initiatives and...

The Wisconsin delegation hit the ground running at BIO 2007, an international conference for the biotechnology industry. Among the significant news generated at BIO was the announcement by Mark Underwood, president of Quincy Biosciences, that the company has developed a preclinical compound for the...

Mason Wells is spinning off its venture capital business, but the move hardly spells doom for Wisconsin's attempts to generate more venture capital. Mason Wells Venture Funds will be spun into Broadwell Ventures, which will be managed by Dan Broderick and focus on biotechnology, pharmaceutical,...

How does Wisconsin stack up to the nation's best biotechnology hubs? This week in Boston, the state will have plenty to thump its chest about at the annual Biotechnology Industry Organization (BIO) Convention, writes columnist Tom Still. In this edition of Inside Wisconsin, he...